Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 1/2 1

Status

Completed 22Unknown 6Recruiting 4Terminated 3Not yet recruiting 3Active not recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polycystic Ovary Syndrome 2Rectal Neoplasms 1Colonic Neoplasms 1

Interventions

Cyclophosphamide 390Carboplatin 344Gemcitabine 332pembrolizumab 329Cisplatin 328Paclitaxel 297Radiotherapy 296Docetaxel 286Bevacizumab 253Rituximab 234Capecitabine 223Nivolumab 220Dexamethasone 206Fluorouracil 190fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 133Cetuximab 129Bortezomib 129fludarabine phosphate 128Lenalidomide 126Erlotinib Hydrochloride 120Filgrastim 119Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Inositol × Clear all
NCT04881851 2025-04-16

IALA

Universita di Verona

Phase NA Terminated
76 enrolled

Polycystic Ovary Syndrome

NCT04306692 2022-12-21

Myo-inositol Versus Clomiphene Citrate in PCOS

University Hospital, Ghent

Phase 4 Terminated
12 enrolled

Polycystic Ovary Syndrome

NCT01111292 2016-07-12

Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia

National Cancer Institute (NCI)

Phase 1/2 Terminated
5 enrolled 7 charts
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡